22.1 C
Delhi
Thursday, October 30, 2025

WHO to drop HCQ from its global study into COVID-19 treatments: Dr Tedros

Date:

Share post:

Donate-GC-Razorpay

Geneva: The World Health Organisation (WHO) is to drop hydroxychloroquine from its global study into COVID-19 treatments. 

Speaking at the Global Media briefing today, Dr Tedros Adhanom Ghebreyesus, Director-General, WHO stated that in light of a paper published last week in The Lancet, that showed people taking hydroxychloroquine (HCQ) were at a higher risk of death and heart-related problems than those who were not taking HCQ. 

Dr Tedros revealed that the Executive Group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity Trial while the data is reviewed by the Data Safety Monitoring Board

“The other arms of the trial are continuing. This concern relates to the use of hydroxychloroquine and chloraquine in #COVID19. I wish to reiterate that these drugs are accepted as generally safe for use in patients with autoimmune diseases or malaria,” Dr Tedros expressed.

Related articles

Odisha’s ₹50,000-Crore Maritime Gambit: A Bold Push to Anchor India’s Eastern Seaboard

When the Odisha delegation took centre stage at the India Maritime Week 2025 in Mumbai, led by Chief...

I Don’t Consent to Lowering the Age of Sexual Consent to 16 in India

India is a nation that prides itself on being young - 65% of our people are under 35....

Is Lenskart IPO a Valuation Bubble?

When a company known for selling spectacles starts to look blurry on the balance sheet, it’s time investors...

Goa 2.0: Brewing an Innovation Hub for AI Startups

Goa is known for many things - beaches, susegad life, and sunsets that make you forget your deadlines....